These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1713729)

  • 1. Iloprost and peripheral arterial disease in diabetic patients.
    Vicari AM; Chiesa R; Mari G; Galimberti M; Di Carlo V; Pozza G
    Acta Diabetol Lat; 1991; 28(1):113-4. PubMed ID: 1713729
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of vasodilating drugs in peripheral vascular disease.
    Karpman HL; Okun R
    Geriatrics; 1972 Nov; 27(11):101-7. PubMed ID: 4562846
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the action of p-chlorophenoxy alpha-isobutyrate of 3-hydroxymethyl pyridine hydrochloride on peripheral circulation. Rheographic and radioisotope studies].
    Modica G; Ferrante R
    Minerva Cardioangiol; 1973 Dec; 21(12):769-74. PubMed ID: 4592148
    [No Abstract]   [Full Text] [Related]  

  • 4. Beneficial effects of eicosapentaenoic acid for diabetic patients with arteriosclerosis obliterans.
    Okuda Y; Mizutami M; Tanaka K; Isaka M; Yamashita K
    Diabetes Res Clin Pract; 1992 Nov; 18(2):139-40. PubMed ID: 1478154
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
    Duthois S; Cailleux N; Lévesque H
    J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study.
    Altstaedt HO; Berzewski B; Breddin HK; Brockhaus W; Bruhn HD; Cachovan M; Diehm C; Dörrler J; Franke CS; Gruss JD
    Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):573-8. PubMed ID: 7692455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA; Pande RL; Hiatt WR
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the therapy of peripheral arteriosclerosis obliterans].
    Pupita F; Stefanelli G
    Minerva Cardioangiol; 1968 Nov; 16(11):1083-93. PubMed ID: 5707453
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R; Pedroni G; Borri P
    Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract]   [Full Text] [Related]  

  • 10. Iloprost in the management of peripheral arterial disease in patients with diabetes mellitus.
    Piaggesi A; Vallini V; Iacopi E; Tedeschi A; Scatena A; Goretti C; Rizzo L
    Minerva Cardioangiol; 2011 Feb; 59(1):101-8. PubMed ID: 21285935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intra-arterial administration of pyrrolidin-methyl-tetracycline in the treatment of various obliterative angiopathies].
    Del Corso P; Zeme D; Beverelli M
    Clin Ter; 1970 Nov; 55(3):231-8. PubMed ID: 5516887
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the therapy of peripheral organo-angiopathies using Progresin].
    Horn HJ
    Med Klin; 1968 Aug; 63(35):1377-8 passim. PubMed ID: 5682033
    [No Abstract]   [Full Text] [Related]  

  • 13. Diabetes mellitus and intermittent claudication. Relation between peripheral vascular complications and location of the occlusive atherosclerosis in the legs.
    Jonason T; Ringqvist I
    Acta Med Scand; 1985; 218(2):217-21. PubMed ID: 4061125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of Tebonin (extract from leaves of ginkgo biloba L.) in the treatment of senile peripheral arteriopathies].
    Locatelli GR; Sorbini E
    Minerva Cardioangiol; 1969 Dec; 17(12):1103-8. PubMed ID: 5373482
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical components in patients with diabetes type II and ischemia of the lower extremities].
    Turczyński B; Sroczyński J; Antoszewski Z; Matyszczyk B; Krupa G; Młynarski J; Strugala M
    Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):708-10. PubMed ID: 1669138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
    Buccellato C; Di Lorenzo GD
    Minerva Chir; 1967 Jun; 22(11):692-5. PubMed ID: 6050666
    [No Abstract]   [Full Text] [Related]  

  • 17. [Considerations on the use of dextran of low molecular weight in the treatment of peripheral arteriopathy].
    Serra GC; Verlato R
    Acta Anaesthesiol; 1965; 16():Suppl 5:87-95. PubMed ID: 5899665
    [No Abstract]   [Full Text] [Related]  

  • 18. [Test of active vasodilatation in the evaluation of peripheral regional circulation in sclerotic and diabetic arteriopathies].
    Dughera L; Macchioni P; Di Leo M; Nosenzo C
    Minerva Cardioangiol; 1972 Sep; 20(9):484-96. PubMed ID: 5071470
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetes mellitus and localizations of obliterating arterial disease of the lower limbs.
    Rubba P; Leccia G; Faccenda F; De Simone B; Carbone L; Pauciullo P; Vaccaro O; Mancini M
    Angiology; 1991 Apr; 42(4):296-301. PubMed ID: 2014920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcutaneous gases determination in diabetic critical limb ischemia.
    Melillo E; Ferrari M; Balbarini A; Pedrinelli R
    Diabetes Care; 2005 Aug; 28(8):2081-2. PubMed ID: 16043766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.